In the last five years, the diagnostic segment of the healthcare sector has seen many ups and downs. During Covid, diagnostic players were overloaded with work and then came the price wars which some new tech companies brought on the table. The price war was essentially started to grab both, market and mind share. While the price war is still on in some segments, there is a possibility that its intensity may come down. The reason, new companies have burnt enough cash and large physical-only players have also made some inroads into digital channels for customer acquisition and also part delivery of the service. Will this bring back focus of the street?
Shares of Thyrocare Technologies were trading 7.33 per cent higher at Rs 751.45. Vijaya Diagnostic Centre was up 5.33 per cent at Rs 501.65. Samsrita Labs jumped 5 per cent while shares of Dr Lalchandani Labs advanced 4 per cent